Subscribe To

Price Alert Latest News Economic Calendar News

WHTCF / WELL Health Technologies earns repeat ‘Buy' rating from two brokers on strong 4Q results and outlook

Analysts at Canaccord Genuity (TSX:CF, LSE:CF) and Stifel GMP have both repeated their ‘Buy' rating for WELL Health Technologies after the digital health company posted stronger-than-anticipated fourth quarter results and upped its 2023 outlook. WELL Health Technologies shares surged 8% on Tuesday after the company posted 4Q revenue of $156.5 million and gross adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of $27.2 million. Read More

Demo Live Account See Partner Details

Content Topics

Well

Health

Technologies

Earns

Repeat

Buy

Rating

From

buy

Brokers

Strong

Results

Outlook

Stock

WHTCF

Posted: Mar 22 2023, 13:01

Author Name: Proactive Investors

WHTCF News

By Proactive Investors
August 10, 2023

WELL Health Technologies posts record 2Q revenue and raises guidance amid expansion of AI-powered healthcare initiatives

WELL Health Technologies Corp (TSX:WELL, OTCQX:WHTCF) shares moved higher after the digital healthcare company posted record second quarter revenue an

By Proactive Investors
May 12, 2023

WELL Health sets quarterly revenue record in 1Q driven by organic growth

WELL Health Technologies Corp (TSX:WELL, OTCQX:WHTCF) released first-quarter results revealing record revenue and upwardly revised guidance. The lar

By Proactive Investors
March 22, 2023

WELL Health Technologies earns repeat ‘Buy' rating from two brokers on strong 4Q results and outlook

Analysts at Canaccord Genuity (TSX:CF, LSE:CF) and Stifel GMP have both repeated their ‘Buy' rating for WELL Health Technologies after the digital

By PRNewsWire
March 14, 2023

WELL Health to Announce Fourth Quarter and Year End 2022 Financial Results on March 21, 2023

VANCOUVER, BC , March 14, 2023 /PRNewswire/ - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital health c

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.